ANCR Symposium
Venue: Scandic Havet (Tollbugata 5)
Programme (preliminary)
Wednesday 28th of August
Pre-symposium
1300-1400 Registration, Baguettes, and refreshments
1400-1700 Workshop 1: Coding and registration, Room: Inspirasjon
1400-1700 Workshop 2: Patient reported outcomes, Room: Storhavet 1
1400-1700 Workshop 3: Modifiable factors in cancer prevention; the role of the cancer registries, Room: Storhavet 2
1330-1700 ANCR Boardmeeting, Room: Forelskelse
1750 Meetup outside the hotel for those who would like to walk as a group to the Town Hall
1800-1900 Welcome Reception Bodø Town Hall, meet up at Town Hall (Kongensgate 23) 18.00 or outside Scandic Havet 17.50
1900-2000 Exploring Bodø and walk to Olivia Restaurant
2000 - Dinner at Olivia Restaurant (Sjøgata 29)
Thursday 29th of August
Welcome and keynote
0900-0910 Giske Ursin - Director, Cancer Registry of Norway - Welcome
0910-0920 Geir Tollåli - Director, Professional Affairs at the Helse Nord RHF
0920-0930 Ingrid Stenstadvold Ross – General Secretary, the Norwegian Cancer Society and Chair Nordic Cancer Union
0930-1000 Anna L. V. Johansson and Siri Larønningen - Keynote: Digging into Nordic Cancer Epidemiology through NORDCAN - Current and Future Perspectives
1000-1015 Short break
Session 1: Patient care epidemiology | Patient reported outcome measures
Chair: Nea Malila and Helgi Birgisson
1015-1025 Yngvar Nilssen: The use of systemic anti-cancer treatment during the last year of life for lung cancer patients in Norway
1025-1035 Denise Reis Costa: Real-World Profile and Treatment Patterns of Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitor (ICI) Therapy in Norway
1035-1045 Victor Falini: Cystectomy for bladder cancer in Sweden – short-term outcomes after centralization
1045-1055 Mona Nilsson: Adverse Health Outcomes (AHOs); Pad use, intercourse inability and quality of life (QoL) three years after Radical Prostatectomy (RP), compared with men in the general population (Norms): A study from the Cancer Registry of Norway (CRN)
1055-1105 Giske Ursin: Effects of digital stress management interventions in women with breast cancer: The Coping After Breast Cancer trial
1105-1125 Coffee break and poster walk
Session 2: Coding and registration of cancer
Chair: Isabelle Soerjomataram and Siri Larønningen
1125-1135 Henrik Møller: Clinical quality indicators and development targets in clinical quality improvement.
1135-1145 Gerda Engholm: TNM stage in the Nordic Cancer Registries 2004-2016: Registration and availability
1145-1155 Johanna Jonsson: Register-based trace back of death certificates in the Swedish Cancer Register: an approach to estimating Death Certificate Initiated Cancer Cases, 2005-2022
1155-1205 Dominik Glombik: Validation of data quality in the Swedish National Penile Cancer Register
1205-1220 Short break
1220-1230 Kristin Oterholt Knudsen: Structured journal for clinical practice and quality registry
Session 3: Early diagnosis and screening
Chair: Henrik Møller and Tytti Sarkeala
1230-1240 Yuqi Zhang: Screen-detected and Interval breast cancer: Temporal trends and risk factors from a Swedish population-based cohort, 1990-2019
1240-1250 Sisse H. Njor: Should residents with a negative colonoscopy in FIT-based screening be quarantined from screening?
1250-1300 Filip Siegfrids: Cost-effectiveness of Organized Risk-based Screening for Breast Cancer in Finland
1300-1400 Lunch
1400-1410 Maiju Pankakoski: Coverage of mammography imaging in and outside an organized breast cancer screening program - Variation by age and sociodemographic groups
1410-1420 Tytti Sarkeala: Integrating intensive smoking cessation with lung cancer screening – a randomized pilot study in Finland and Hungary
1420-1430 Markus D. Knudsen: Colorectal cancer incidence and mortality after negative colonoscopy screening: a cohort study
1430-1440 Susanne F. Jørgensen: How do socioeconomic factors affect the longitudinal adherence to colonoscopy surveillance in the Danish FIT-based colorectal cancer screening program
1440-1500 Coffee break and poster walk
Session 4: Causes and risk factors
Chair: Sigríður Gunnarsdóttir and David Pettersson
1500-1510 Allan Jensen: Risk of breast cancer among women with hyper- and hypothyroidism: Results from a large nationwide cohort study
1510-1520 Paula Berstad: A substantial proportion of the association between alcohol consumption and colorectal carcinogenesis is mediated by the gut microbiome
1520-1530 Maarit Lamminmäki: A population-based cohort study on changes in lung and bladder cancer incidence among non-Western immigrant men
1530-1540 Eetu Mäkinen: The effect of diabetes and its complications on the risk of colorectal cancer
1540-1550 Karri Seppä: Cost of breast cancer treatment attributable to modifiable risk factors in Finland
1550-1600 Sanna Heikkinen: Rheumatoid arthritis and the risk of common cancers
1600-1630 Hotdogs served at Havneutsikten restaurant at Scandic Havet
1640 Departure for RIB trip from the Hotel reception to the "Hurtigrutekaia"
Wear decent foot-wear, gore-tex or the like. Regular clothing for a mountain walk. You may NOT bring bags or the like with Dinner attire. Kindly organise this with colleagues travelling by bus. You will be provided with a floating dress, hat, googles, gloves at the quay.
1700-1830 Bodø -Saltstraumen Hotel by RIB
1730 Meetup at Hotel Lobby for Bus departure
1745-1845 Bodø-Saltstraumen Hotel by bus
1900-2200 Symposium Dinner at Saltstraumen Hotel
2200-2300 Bus Saltstraumen Hotel – Scandic Havet
Friday 30th of August
0900-0930 Elisabete Weiderpass - Keynote: Global Cancer Burden: Research and Strategies for Cancer Precention
Session 5: Epidemiological and biostatistical methods
Chair: Anna L. V. Johansson and Janne Pitkaniemi
0930-0940 Paul Lambert: A practical approach to fitting cancer survival models when data can’t move across borders.
0940-0950 Jan Nygård: Synthetic data generation for external control arms
0950-1000 Aapeli Nevala: When you got nothing but time - Bayesian latent regression for progressive disease with selectively observed outcomes
1000-1010 Eva M. Gudmundsdottir: Prediction of cancer incidence and prevalence in Iceland up to the year 2040
1010-1040 Break and checking out
Session 6: Surveillance and Survival from Cancer
Chair: Paul Lambert and Tor Åge Myklebust
1040-1050 Leo Gkekos: Tumour characteristics and prognosis in women with breast cancer diagnosed during pregnancy and two years after delivery
1050-1100 Anders Vikerfors: Urinary tract infections and bladder cancer mortality in a nationwide cohort study
1100-1110 Helga H. Hektoen: Real world survival for patients with advanced non-small cell lung cancer treated with pembrolizumab as single agent or in combination with chemotherapy
1110-1120 Elisavet Syriopoulou: Survival disparities in colorectal cancer: investigating the role of stage at diagnosis through mediation analysis
1120-1130 Lukas Löfling: Beta-blockers and Epithelial Ovarian Cancer Survival: A Norwegian Population-based Cohort Study
1130-1200 Coffee break
1200-1210 Anna L. V. Johansson: Cancer incidence and stage during the COVID-19 pandemic 2020 and 2021: A Nordic study
1210-1220 Janne Pitkäniemi: Excess mortality among cancer patients increased during Covid-19 in Nordic countries
1220-1230 Nea Malila: Gleason score extraction for predicting survival of prostate cancer patients
1230-1300 Closure and AWARD
1300-1400 LUNCH
1400-1630 Hiking to Keiservarden for those spending some extra time in Bodø, meet up in the Hotel Reception at 14.00
Follow this link for more information: https://ancr2024.mmevent.no/hjem.
For an overview of previous ANCR-symposiums, please visit this site.
Information on the previous ANCR symposium, held 6-8 September 2023 in Hotel Paasitorni, Helsinki, Finland, can be found here: ANCR symposium website.